オンコロジー市場- がん診断・治療法別、がん種別、エンドユーザー別＆予測、2023年～2032年

オンコロジー市場は、世界のがん罹患率の上昇を背景に、2023年から2032年にかけて顕著な伸びを示すと予想されています。

WHOの統計によると、がんは世界の死亡原因の1つであり、2020年には約1,000万人が死亡するとされています。このため、この病気を治療するための幅広い治療法の選択肢が求められています。化学療法、外科療法、放射線療法などの様々な治療法が、がん治療における治癒効果だけでなく、緩和効果ももたらすという重要な利点があるため、がん治療に採用されています。

新興経済諸国の研究者、政府関係者、市場関係者による技術革新は、2032年までの業界の成長にさらに影響を与えるでしょう。例えば、英国の政府技術移転庁（GOTT）は、乳がん診断を強化するための超音波技術の新規開発について、国立物理研究所に資金を提供しました。

オンコロジー産業は、がん診断・治療、がん、最終用途、地域に区分されます。

がんの診断と治療に基づくと、がんの診断分野は、時間の経過とともに有益なリターンをもたらすと予想されます。この分野の成長を促進する基本的な要因としては、がんの発生率の増加やこの分野における技術的進歩が挙げられます。また、健康診断やバイオマーカー検査だけでがんを発見するのは単調な作業であり、画像検査はがんを確定するために不可欠であるとも言われています。このような動向は、先進的な画像診断の需要を喚起し、市場の成長を促しています。

がんについては、肥満やホルモンバランスの乱れ、加齢に伴うリスクの増加により、乳がんが急増しているため、今後10年間で乳がん分野の市場シェアが大幅に増加すると予想されます。Cancer.netの統計によると、2023年には米国で乳がんによる死者が43,500人以上になると予測されています。また、ニュージーランドなどのBreastScreen Aotearoaのような様々な政府の取り組みが、女性に無料の検査を提供することで、市場規模をさらに押し上げるでしょう。

腫瘍学治療は、近年、専門クリニックで行われることが多くなっています。これらのヘルスケア施設は、特定の種類のがん治療に対応する高度ながん治療施設として機能しています。このような医療施設では、がんの発見やスクリーニングのための高度な技術や専門の腫瘍医が利用できるようになり、事業の成長をさらに後押ししています。

また、検診や診断のための高度な技術を利用できるようになれば、がん治療のための魅力的な機会を患者に提供できることは言うまでもないです。

地域的には、アジア太平洋地域がオンコロジー産業のホットスポットとして浮上する可能性があります。報告書によると、APACのオンコロジー市場は、2023年から2032年の間に11.5%以上のCAGRで成長すると予測されています。この地域の成長は、インド、日本、中国などの国々でがんの症例が急増していることに起因しているものと思われます。ちなみに、がん登録データによると、インドでは毎年約80万人のがん患者が新たに発生することが明らかにされています。

さらに、アジア太平洋地域の主要製薬会社が新たに開発したがん治療薬について、地域住民の間で認知度が高まっていることも、今後数年間の市場成長を促進するものと思われます。

目次

第1章 調査手法とスコープ

第2章 エグゼクティブサマリー

第3章 オンコロジー業界洞察

• 業界別セグメンテーション
• 業界情勢の推移、2018年～2032年
• 業界への影響要因
  • 促進要因
    • 世界のがん罹患率の上昇
    • 病気に対する認識を広めるために、政府および他の組織別行われたいくつかの取り組み
    • 発展途上国で増加する診断所数
    • 先進国の技術の進歩
  • 業界の潜在的リスク＆課題
    • 高額な設備投資と画像診断システムのコスト高
    • がん治療に伴う副作用やCTスキャナーに伴うリスクも高い
    • 熟練した訓練を受けた腫瘍医や放射線科医の不足
• 成長性分析
  • がん診断・治療薬別
  • がんの種類別
  • エンドユーズ別
• COVID-19影響分析
• オンコロジー臨床試験量分析、2021年
  • オンコロジークリニカルトライアル量、地域別、2017年～2021年
  • オンコロジー臨床試験量、がん種別、2017年～2021年
  • オンコロジー臨床試験量、開発段階別、2017年～2021年
• パイプラインの解析
• ポーター分析
• PESTEL分析

第4章 競合情勢、2021年

• イントロダクション
• カンパニーマトリックス分析
• がん治療薬の上位製品、企業別、2021年
• 主要市場プレイヤーの競合分析
  • F. Hoffmann-La Roche
  • Janssen Diagnostics, LCC
  • Pfizer, Inc
  • GE Healthcare
• オンコロジー医薬品企業シェア分析、2021年
• 戦略的なダッシュボード

第5章 オンコロジー市場：がん診断薬・治療薬別

• がん診断・治療の主な動向
• がん診断薬
  • 腫瘍バイオマーカー検査
  • イメージング
  • 生検
  • リキッドバイオプシー
  • イムノヒストケミストリー
  • インサイチュハイブリダイゼーション
• がん治療
  • イムノヒストケミストリー
  • 標的療法
  • 免疫療法
  • ホルモン療法
  • その他

第6章 オンコロジー市場：がんタイプ別

• 主ながん種の動向
• 肺がん
• 前立腺がん
• 結腸・直腸がん
• 胃がん
• 食道がん
• 肝臓がん
• 乳がん
• その他

第7章 オンコロジー市場：エンドユーザー別

• 主なエンドユーザー動向
• 病院
• 診断ラボラトリー
• 画像診断センター
• アカデミア
• スペシャリティクリニック
• その他

第8章 オンコロジー市場：領域別

• 主な地域動向
• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • 英国
  • フランス
  • スペイン
  • イタリア
  • ポーランド
  • スイス
  • オランダ
• アジア太平洋地域
  • 中国
  • インド
  • 日本
  • オーストラリア
  • 韓国
  • インドネシア
  • タイ
  • ベトナム
• ラテンアメリカ
  • ブラジル
  • メキシコ
  • アルゼンチン
  • コロンビア
• MEA
  • 南アフリカ
  • サウジアラビア
  • UAE
  • イスラエル

第9章 企業プロファイル

• Abbott
• Bayer AG
• Biocartis
• BioMerieux SA
• Bio-Rad Laboratories
• GE Healthcare
• Astellas Pharma, Inc.
• AstraZeneca
• Janssen Diagnostic LLC（Johnson & Johnson）
• F. Hoffmann-La Roche Ltd
• Sysmex Corporation
• Thermo Fischer Scientific
• Siemens Healthineers
• Kite Pharma（Gilead Sciences Inc）
• Amgen
• AstraZeneca
• Merck & Co.
• Abbive Inc.
• Pfizer

Data Tables

• TABLE 1. Market revenue, by cancer diagnostics & treatment (2022)
• TABLE 2. Market revenue, by cancer type (2022)
• TABLE 3. Market revenue, by end-use (2022)
• TABLE 4. Market share, by region (2022)
• TABLE 5. Global oncology market, 2018-2022 (USD Million)
• TABLE 6. Global oncology market, 2023-2032 (USD Million)
• TABLE 7. Global oncology market, by cancer diagnostics & treatment, 2018-2022 (USD Million)
• TABLE 8. Global oncology market, by cancer diagnostics & treatment, 2023-2032 (USD Million)
• TABLE 9. Global oncology market, by cancer type, 2018-2022 (USD Million)
• TABLE 10. Global oncology market, by cancer type, 2023-2032 (USD Million)
• TABLE 11. Global oncology market, by end-use, 2018-2022 (USD Million)
• TABLE 12. Global oncology market, by end-use, 2023-2032 (USD Million)
• TABLE 13. Global oncology market, by region, 2018-2022 (USD Million)
• TABLE 14. Global oncology market, by region, 2023-2032 (USD Million)
• TABLE 15. Industry impact forces
• TABLE 16. Cancer diagnostics market size, 2018-2022 (USD Million)
• TABLE 17. Cancer diagnostics market size, 2023-2032 (USD Million)
• TABLE 18. Tumor biomarkers tests market size, 2018-2022 (USD Million)
• TABLE 19. Tumor biomarkers tests market size, 2023-2032 (USD Million)
• TABLE 20. Imaging market size, 2018-2022 (USD Million)
• TABLE 21. Imaging market size, 2023-2032 (USD Million)
• TABLE 22. Biopsy market size, 2018-2022 (USD Million)
• TABLE 23. Biopsy market size, 2023-2032 (USD Million)
• TABLE 24. Liquid biopsy market size, 2018-2022 (USD Million)
• TABLE 25. Liquid biopsy market size, 2023-2032 (USD Million)
• TABLE 26. Immunohistochemistry market size, 2018-2022 (USD Million)
• TABLE 27. Immunohistochemistry market size, 2023-2032 (USD Million)
• TABLE 28. In situ hybridization market size, 2018-2022 (USD Million)
• TABLE 29. In situ hybridization market size, 2023-2032 (USD Million)
• TABLE 30. Cancer treatment market size, 2018-2022 (USD Million)
• TABLE 31. Cancer treatment market size, 2023-2032 (USD Million)
• TABLE 32. Chemotherapy market size, 2018-2022 (USD Million)
• TABLE 33. Chemotherapy market size, 2023-2032 (USD Million)
• TABLE 34. Targeted therapy market size, 2018-2022 (USD Million)
• TABLE 35. Targeted therapy market size, 2023-2032 (USD Million)
• TABLE 36. Immunotherapy market size, 2018-2022 (USD Million)
• TABLE 37. Immunotherapy market size, 2023-2032 (USD Million)
• TABLE 38. Hormonal therapy market size, 2018-2022 (USD Million)
• TABLE 39. Hormonal therapy market size, 2023-2032 (USD Million)
• TABLE 40. Others market size, 2018-2022 (USD Million)
• TABLE 41. Others market size, 2023-2032 (USD Million)
• TABLE 42. Lung cancer market size, 2018-2022 (USD Million)
• TABLE 43. Lung cancer market size, 2023-2032 (USD Million)
• TABLE 44. Prostate cancer market size, 2018-2022 (USD Million)
• TABLE 45. Prostate cancer market size, 2023-2032 (USD Million)
• TABLE 46. Colon and rectal cancer market size, 2018-2022 (USD Million)
• TABLE 47. Colon and rectal cancer market size, 2023-2032 (USD Million)
• TABLE 48. Gastric cancer market size, 2018-2022 (USD Million)
• TABLE 49. Gastric cancer market size, 2023-2032 (USD Million)
• TABLE 50. Esophageal cancer market size, 2018-2022 (USD Million)
• TABLE 51. Esophageal cancer market size, 2023-2032 (USD Million)
• TABLE 52. Liver market size, 2018-2022 (USD Million)
• TABLE 53. Liver market size, 2023-2032 (USD Million)
• TABLE 54. Breast cancer market size, 2018-2022 (USD Million)
• TABLE 55. Breast cancer market size, 2023-2032 (USD Million)
• TABLE 56. Others market size, 2018-2022 (USD Million)
• TABLE 57. Others market size, 2023-2032 (USD Million)
• TABLE 58. Hospitals market size, 2018-2022 (USD Million)
• TABLE 59. Hospitals market size, 2023-2032 (USD Million)
• TABLE 60. Diagnostic laboratories market size, 2018-2022 (USD Million)
• TABLE 61. Diagnostic laboratories market size, 2023-2032 (USD Million)
• TABLE 62. Diagnostic imaging centers market size, 2018-2022 (USD Million)
• TABLE 63. Diagnostic imaging centers market size, 2023-2032 (USD Million)
• TABLE 64. Academia market size, 2018-2022 (USD Million)
• TABLE 65. Academia market size, 2023-2032 (USD Million)
• TABLE 66. Specialty clinics market size, 2018-2022 (USD Million)
• TABLE 67. Specialty clinics market size, 2023-2032 (USD Million)
• TABLE 68. Others market size, 2018-2022 (USD Million)
• TABLE 69. Others market size, 2023-2032 (USD Million)
• TABLE 70. North America oncology market size, by country, 2018-2022 (USD Million)
• TABLE 71. North America oncology market size, by country, 2023-2032 (USD Million)
• TABLE 72. North America oncology market size, by cancer diagnostics & treatment, 2018-2022 (USD Million)
• TABLE 73. North America oncology market size, by cancer diagnostics & treatment, 2023-2032 (USD Million)
• TABLE 74. North America oncology market size, by cancer diagnostics, 2018-2022 (USD Million)
• TABLE 75. North America oncology market size, by cancer diagnostics, 2023-2032 (USD Million)
• TABLE 76. North America oncology market size, by cancer treatment, 2018-2022 (USD Million)
• TABLE 77. North America oncology market size, by cancer treatment, 2023-2032 (USD Million)
• TABLE 78. North America oncology market size, by cancer type, 2018-2022 (USD Million)
• TABLE 79. North America oncology market size, by cancer type, 2023-2032 (USD Million)
• TABLE 80. North America oncology market size, by end-use, 2018-2022 (USD Million)
• TABLE 81. North America oncology market size, by end-use, 2023-2032 (USD Million)
• TABLE 82. U.S. oncology market size, by cancer diagnostics & treatment, 2018-2022 (USD Million)
• TABLE 83. U.S. oncology market size, by cancer diagnostics & treatment, 2023-2032 (USD Million)
• TABLE 84. U.S. oncology market size, by cancer diagnostics, 2018-2022 (USD Million)
• TABLE 85. U.S. oncology market size, by cancer diagnostics, 2023-2032 (USD Million)
• TABLE 86. U.S. oncology market size, by cancer treatment, 2018-2022 (USD Million)
• TABLE 87. U.S. oncology market size, by cancer treatment, 2023-2032 (USD Million)
• TABLE 88. U.S. oncology market size, by cancer type, 2018-2022 (USD Million)
• TABLE 89. U.S. oncology market size, by cancer type, 2023-2032 (USD Million)
• TABLE 90. U.S. oncology market size, by end-use, 2018-2022 (USD Million)
• TABLE 91. U.S. oncology market size, by end-use, 2023-2032 (USD Million)
• TABLE 92. Canada oncology market size, by cancer diagnostics & treatment, 2018-2022 (USD Million)
• TABLE 93. Canada oncology market size, by cancer diagnostics & treatment, 2023-2032 (USD Million)
• TABLE 94. Canada oncology market size, by cancer diagnostics, 2018-2022 (USD Million)
• TABLE 95. Canada oncology market size, by cancer diagnostics, 2023-2032 (USD Million)
• TABLE 96. Canada oncology market size, by cancer treatment, 2018-2022 (USD Million)
• TABLE 97. Canada oncology market size, by cancer treatment, 2023-2032 (USD Million)
• TABLE 98. Canada oncology market size, by cancer type, 2018-2022 (USD Million)
• TABLE 99. Canada oncology market size, by cancer type, 2023-2032 (USD Million)
• TABLE 100. Canada oncology market size, by end-use, 2018-2022 (USD Million)
• TABLE 101. Canada oncology market size, by end-use, 2023-2032 (USD Million)
• TABLE 102. Europe oncology market size, by country, 2018-2022 (USD Million)
• TABLE 103. Europe oncology market size, by country, 2023-2032 (USD Million)
• TABLE 104. Europe oncology market size, by cancer diagnostics & treatment, 2018-2022 (USD Million)
• TABLE 105. Europe oncology market size, by cancer diagnostics & treatment, 2023-2032 (USD Million)
• TABLE 106. Europe oncology market size, by cancer diagnostics, 2018-2022 (USD Million)
• TABLE 107. Europe oncology market size, by cancer diagnostics, 2023-2032 (USD Million)
• TABLE 108. Europe oncology market size, by cancer treatment, 2018-2022 (USD Million)
• TABLE 109. Europe oncology market size, by cancer treatment, 2023-2032 (USD Million)
• TABLE 110. Europe oncology market size, by cancer type, 2018-2022 (USD Million)
• TABLE 111. Europe oncology market size, by cancer type, 2023-2032 (USD Million)
• TABLE 112. Europe oncology market size, by end-use, 2018-2022 (USD Million)
• TABLE 113. Europe oncology market size, by end-use, 2023-2032 (USD Million)
• TABLE 114. Germany oncology market size, by cancer diagnostics & treatment, 2018-2022 (USD Million)
• TABLE 115. Germany oncology market size, by cancer diagnostics & treatment, 2023-2032 (USD Million)
• TABLE 116. Germany oncology market size, by cancer diagnostics, 2018-2022 (USD Million)
• TABLE 117. Germany oncology market size, by cancer diagnostics, 2023-2032 (USD Million)
• TABLE 118. Germany oncology market size, by cancer treatment, 2018-2022 (USD Million)
• TABLE 119. Germany oncology market size, by cancer treatment, 2023-2032 (USD Million)
• TABLE 120. Germany oncology market size, by cancer type, 2018-2022 (USD Million)
• TABLE 121. Germany oncology market size, by cancer type, 2023-2032 (USD Million)
• TABLE 122. Germany oncology market size, by end-use, 2018-2022 (USD Million)
• TABLE 123. Germany oncology market size, by end-use, 2023-2032 (USD Million)
• TABLE 124. UK oncology market size, by cancer diagnostics & treatment, 2018-2022 (USD Million)
• TABLE 125. UK oncology market size, by cancer diagnostics & treatment, 2023-2032 (USD Million)
• TABLE 126. UK oncology market size, by cancer diagnostics, 2018-2022 (USD Million)
• TABLE 127. UK oncology market size, by cancer diagnostics, 2023-2032 (USD Million)
• TABLE 128. UK oncology market size, by cancer treatment, 2018-2022 (USD Million)
• TABLE 129. UK oncology market size, by cancer treatment, 2023-2032 (USD Million)
• TABLE 130. UK oncology market size, by cancer type, 2018-2022 (USD Million)
• TABLE 131. UK oncology market size, by cancer type, 2023-2032 (USD Million)
• TABLE 132. UK oncology market size, by end-use, 2018-2022 (USD Million)
• TABLE 133. UK oncology market size, by end-use, 2023-2032 (USD Million)
• TABLE 134. France oncology market size, by cancer diagnostics & treatment, 2018-2022 (USD Million)
• TABLE 135. France oncology market size, by cancer diagnostics & treatment, 2023-2032 (USD Million)
• TABLE 136. France oncology market size, by cancer diagnostics, 2018-2022 (USD Million)
• TABLE 137. France oncology market size, by cancer diagnostics, 2023-2032 (USD Million)
• TABLE 138. France oncology market size, by cancer treatment, 2018-2022 (USD Million)
• TABLE 139. France oncology market size, by cancer treatment, 2023-2032 (USD Million)
• TABLE 140. France oncology market size, by cancer type, 2018-2022 (USD Million)
• TABLE 141. France oncology market size, by cancer type, 2023-2032 (USD Million)
• TABLE 142. France oncology market size, by end-use, 2018-2022 (USD Million)
• TABLE 143. France oncology market size, by end-use, 2023-2032 (USD Million)
• TABLE 144. Spain oncology market size, by cancer diagnostics & treatment, 2018-2022 (USD Million)
• TABLE 145. Spain oncology market size, by cancer diagnostics & treatment, 2023-2032 (USD Million)
• TABLE 146. Spain oncology market size, by cancer diagnostics, 2018-2022 (USD Million)
• TABLE 147. Spain oncology market size, by cancer diagnostics, 2023-2032 (USD Million)
• TABLE 148. Spain oncology market size, by cancer treatment, 2018-2022 (USD Million)
• TABLE 149. Spain oncology market size, by cancer treatment, 2023-2032 (USD Million)
• TABLE 150. Spain oncology market size, by cancer type, 2018-2022 (USD Million)
• TABLE 151. Spain oncology market size, by cancer type, 2023-2032 (USD Million)
• TABLE 152. Spain oncology market size, by end-use, 2018-2022 (USD Million)
• TABLE 153. Spain oncology market size, by end-use, 2023-2032 (USD Million)
• TABLE 154. Italy oncology market size, by cancer diagnostics & treatment, 2018-2022 (USD Million)
• TABLE 155. Italy oncology market size, by cancer diagnostics & treatment, 2023-2032 (USD Million)
• TABLE 156. Italy oncology market size, by cancer diagnostics, 2018-2022 (USD Million)
• TABLE 157. Italy oncology market size, by cancer diagnostics, 2023-2032 (USD Million)
• TABLE 158. Italy oncology market size, by cancer treatment, 2018-2022 (USD Million)
• TABLE 159. Italy oncology market size, by cancer treatment, 2023-2032 (USD Million)
• TABLE 160. Italy oncology market size, by cancer type, 2018-2022 (USD Million)
• TABLE 161. Italy oncology market size, by cancer type, 2023-2032 (USD Million)
• TABLE 162. Italy oncology market size, by end-use, 2018-2022 (USD Million)
• TABLE 163. Italy oncology market size, by end-use, 2023-2032 (USD Million)
• TABLE 164. Poland oncology market size, by cancer diagnostics & treatment, 2018-2022 (USD Million)
• TABLE 165. Poland oncology market size, by cancer diagnostics & treatment, 2023-2032 (USD Million)
• TABLE 166. Poland oncology market size, by cancer diagnostics, 2018-2022 (USD Million)
• TABLE 167. Poland oncology market size, by cancer diagnostics, 2023-2032 (USD Million)
• TABLE 168. Poland oncology market size, by cancer treatment, 2018-2022 (USD Million)
• TABLE 169. Poland oncology market size, by cancer treatment, 2023-2032 (USD Million)
• TABLE 170. Poland oncology market size, by cancer type, 2018-2022 (USD Million)
• TABLE 171. Poland oncology market size, by cancer type, 2023-2032 (USD Million)
• TABLE 172. Poland oncology market size, by end-use, 2018-2022 (USD Million)
• TABLE 173. Poland oncology market size, by end-use, 2023-2032 (USD Million)
• TABLE 174. Switzerland oncology market size, by cancer diagnostics & treatment, 2018-2022 (USD Million)
• TABLE 175. Switzerland oncology market size, by cancer diagnostics & treatment, 2023-2032 (USD Million)
• TABLE 176. Switzerland oncology market size, by cancer diagnostics, 2018-2022 (USD Million)
• TABLE 177. Switzerland oncology market size, by cancer diagnostics, 2023-2032 (USD Million)
• TABLE 178. Switzerland oncology market size, by cancer treatment, 2018-2022 (USD Million)
• TABLE 179. Switzerland oncology market size, by cancer treatment, 2023-2032 (USD Million)
• TABLE 180. Switzerland oncology market size, by cancer type, 2018-2022 (USD Million)
• TABLE 181. Switzerland oncology market size, by cancer type, 2023-2032 (USD Million)
• TABLE 182. Switzerland oncology market size, by end-use, 2018-2022 (USD Million)
• TABLE 183. Switzerland oncology market size, by end-use, 2023-2032 (USD Million)
• TABLE 184. Netherlands oncology market size, by cancer diagnostics & treatment, 2018-2022 (USD Million)
• TABLE 185. Netherlands oncology market size, by cancer diagnostics & treatment, 2023-2032 (USD Million)
• TABLE 186. Netherlands oncology market size, by cancer diagnostics, 2018-2022 (USD Million)
• TABLE 187. Netherlands oncology market size, by cancer diagnostics, 2023-2032 (USD Million)
• TABLE 188. Netherlands oncology market size, by cancer treatment, 2018-2022 (USD Million)
• TABLE 189. Netherlands oncology market size, by cancer treatment, 2023-2032 (USD Million)
• TABLE 190. Netherlands oncology market size, by cancer type, 2018-2022 (USD Million)
• TABLE 191. Netherlands oncology market size, by cancer type, 2023-2032 (USD Million)
• TABLE 192. Netherlands oncology market size, by end-use, 2018-2022 (USD Million)
• TABLE 193. Netherlands oncology market size, by end-use, 2023-2032 (USD Million)
• TABLE 194. Asia Pacific oncology market size, by country, 2018-2022 (USD Million)
• TABLE 195. Europe oncology market size, by country, 2023-2032 (USD Million)
• TABLE 196. Asia Pacific oncology market size, by cancer diagnostics & treatment, 2018-2022 (USD Million)
• TABLE 197. Asia Pacific oncology market size, by cancer diagnostics & treatment, 2023-2032 (USD Million)
• TABLE 198. Asia Pacific oncology market size, by cancer diagnostics, 2018-2022 (USD Million)
• TABLE 199. Asia Pacific oncology market size, by cancer diagnostics, 2023-2032 (USD Million)
• TABLE 200. Asia Pacific oncology market size, by cancer treatment, 2018-2022 (USD Million)
• TABLE 201. Asia Pacific oncology market size, by cancer treatment, 2023-2032 (USD Million)
• TABLE 202. Asia Pacific oncology market size, by cancer type, 2018-2022 (USD Million)
• TABLE 203. Asia Pacific oncology market size, by cancer type, 2023-2032 (USD Million)
• TABLE 204. Asia Pacific oncology market size, by end-use, 2018-2022 (USD Million)
• TABLE 205. Asia Pacific oncology market size, by end-use, 2023-2032 (USD Million)
• TABLE 206. China oncology market size, by cancer diagnostics & treatment, 2018-2022 (USD Million)
• TABLE 207. China oncology market size, by cancer diagnostics & treatment, 2023-2032 (USD Million)
• TABLE 208. China oncology market size, by cancer diagnostics, 2018-2022 (USD Million)
• TABLE 209. China oncology market size, by cancer diagnostics, 2023-2032 (USD Million)
• TABLE 210. China oncology market size, by cancer treatment, 2018-2022 (USD Million)
• TABLE 211. China oncology market size, by cancer treatment, 2023-2032 (USD Million)
• TABLE 212. China oncology market size, by cancer type, 2018-2022 (USD Million)
• TABLE 213. China oncology market size, by cancer type, 2023-2032 (USD Million)
• TABLE 214. China oncology market size, by end-use, 2018-2022 (USD Million)
• TABLE 215. China market size, by end-use, 2023-2032 (USD Million)
• TABLE 216. India oncology market size, by cancer diagnostics & treatment, 2018-2022 (USD Million)
• TABLE 217. India oncology market size, by cancer diagnostics & treatment, 2023-2032 (USD Million)
• TABLE 218. India oncology market size, by cancer diagnostics, 2018-2022 (USD Million)
• TABLE 219. India oncology market size, by cancer diagnostics, 2023-2032 (USD Million)
• TABLE 220. India oncology market size, by cancer treatment, 2018-2022 (USD Million)
• TABLE 221. India oncology market size, by cancer treatment, 2023-2032 (USD Million)
• TABLE 222. India oncology market size, by cancer type, 2018-2022 (USD Million)
• TABLE 223. India oncology market size, by cancer type, 2023-2032 (USD Million)
• TABLE 224. India oncology market size, by end-use, 2018-2022 (USD Million)
• TABLE 225. India oncology market size, by end-use, 2023-2032 (USD Million)
• TABLE 226. Japan oncology market size, by cancer diagnostics & treatment, 2018-2022 (USD Million)
• TABLE 227. Japan oncology market size, by cancer diagnostics & treatment, 2023-2032 (USD Million)
• TABLE 228. Japan oncology market size, by cancer diagnostics, 2018-2022 (USD Million)
• TABLE 229. Japan oncology market size, by cancer diagnostics, 2023-2032 (USD Million)
• TABLE 230. Japan oncology market size, by cancer treatment, 2018-2022 (USD Million)
• TABLE 231. Japan oncology market size, by cancer treatment, 2023-2032 (USD Million)
• TABLE 232. Japan oncology market size, by cancer type, 2018-2022 (USD Million)
• TABLE 233. Japan oncology market size, by cancer type, 2023-2032 (USD Million)
• TABLE 234. Japan oncology market size, by end-use, 2018-2022 (USD Million)
• TABLE 235. Japan oncology market size, by end-use, 2023-2032 (USD Million)
• TABLE 236. Australia oncology market size, by cancer diagnostics & treatment, 2018-2022 (USD Million)
• TABLE 237. Australia oncology market size, by cancer diagnostics & treatment, 2023-2032 (USD Million)
• TABLE 238. Australia oncology market size, by cancer diagnostics, 2018-2022 (USD Million)
• TABLE 239. Australia oncology market size, by cancer diagnostics, 2023-2032 (USD Million)
• TABLE 240. Australia oncology market size, by cancer treatment, 2018-2022 (USD Million)
• TABLE 241. Australia oncology market size, by cancer treatment, 2023-2032 (USD Million)
• TABLE 242. Australia oncology market size, by cancer type, 2018-2022 (USD Million)
• TABLE 243. Australia oncology market size, by cancer type, 2023-2032 (USD Million)
• TABLE 244. Australia oncology market size, by end-use, 2018-2022 (USD Million)
• TABLE 245. Australia oncology market size, by end-use, 2023-2032 (USD Million)
• TABLE 246. South Korea oncology market size, by cancer diagnostics & treatment, 2018-2022 (USD Million)
• TABLE 247. South Korea oncology market size, by cancer diagnostics & treatment, 2023-2032 (USD Million)
• TABLE 248. South Korea oncology market size, by cancer diagnostics, 2018-2022 (USD Million)
• TABLE 249. South Korea oncology market size, by cancer diagnostics, 2023-2032 (USD Million)
• TABLE 250. South Korea oncology market size, by cancer treatment, 2018-2022 (USD Million)
• TABLE 251. South Korea oncology market size, by cancer treatment, 2023-2032 (USD Million)
• TABLE 252. South Korea oncology market size, by cancer type, 2018-2022 (USD Million)
• TABLE 253. South Korea oncology market size, by cancer type, 2023-2032 (USD Million)
• TABLE 254. South Korea oncology market size, by end-use, 2018-2022 (USD Million)
• TABLE 255. South Korea oncology market size, by end-use, 2023-2032 (USD Million)
• TABLE 256. Indonesia oncology market size, by cancer diagnostics & treatment, 2018-2022 (USD Million)
• TABLE 257. Indonesia oncology market size, by cancer diagnostics & treatment, 2023-2032 (USD Million)
• TABLE 258. Indonesia oncology market size, by cancer diagnostics, 2018-2022 (USD Million)
• TABLE 259. Indonesia oncology market size, by cancer diagnostics, 2023-2032 (USD Million)
• TABLE 260. Indonesia oncology market size, by cancer treatment, 2018-2022 (USD Million)
• TABLE 261. Indonesia oncology market size, by cancer treatment, 2023-2032 (USD Million)
• TABLE 262. Indonesia oncology market size, by cancer type, 2018-2022 (USD Million)
• TABLE 263. Indonesia oncology market size, by cancer type, 2023-2032 (USD Million)
• TABLE 264. Indonesia oncology market size, by end-use, 2018-2022 (USD Million)
• TABLE 265. Indonesia oncology market size, by end-use, 2023-2032 (USD Million)
• TABLE 266. Thailand oncology market size, by cancer diagnostics & treatment, 2018-2022 (USD Million)
• TABLE 267. Thailand oncology market size, by cancer diagnostics & treatment, 2023-2032 (USD Million)
• TABLE 268. Thailand oncology market size, by cancer diagnostics, 2018-2022 (USD Million)
• TABLE 269. Thailand oncology market size, by cancer diagnostics, 2023-2032 (USD Million)
• TABLE 270. Thailand oncology market size, by cancer treatment, 2018-2022 (USD Million)
• TABLE 271. Thailand oncology market size, by cancer treatment, 2023-2032 (USD Million)
• TABLE 272. Thailand oncology market size, by cancer type, 2018-2022 (USD Million)
• TABLE 273. Thailand oncology market size, by cancer type, 2023-2032 (USD Million)
• TABLE 274. Thailand oncology market size, by end-use, 2018-2022 (USD Million)
• TABLE 275. Thailand oncology market size, by end-use, 2023-2032 (USD Million)
• TABLE 276. Vietnam oncology market size, by cancer diagnostics & treatment, 2018-2022 (USD Million)
• TABLE 277. Vietnam oncology market size, by cancer diagnostics & treatment, 2023-2032 (USD Million)
• TABLE 278. Vietnam oncology market size, by cancer diagnostics, 2018-2022 (USD Million)
• TABLE 279. Vietnam oncology market size, by cancer diagnostics, 2023-2032 (USD Million)
• TABLE 280. Vietnam oncology market size, by cancer treatment, 2018-2022 (USD Million)
• TABLE 281. Vietnam oncology market size, by cancer treatment, 2023-2032 (USD Million)
• TABLE 282. Vietnam oncology market size, by cancer type, 2018-2022 (USD Million)
• TABLE 283. Vietnam oncology market size, by cancer type, 2023-2032 (USD Million)
• TABLE 284. Vietnam oncology market size, by end-use, 2018-2022 (USD Million)
• TABLE 285. Vietnam oncology market size, by end-use, 2023-2032 (USD Million)
• TABLE 286. Latin America oncology market size, by country, 2018-2022 (USD Million)
• TABLE 287. Latin America oncology market size, by country, 2023-2032 (USD Million)
• TABLE 288. Latin America oncology market size, by cancer diagnostics & treatment, 2018-2022 (USD Million)
• TABLE 289. Latin America oncology market size, by cancer diagnostics & treatment, 2023-2032 (USD Million)
• TABLE 290. Latin America oncology market size, by cancer diagnostics, 2018-2022 (USD Million)
• TABLE 291. Latin America oncology market size, by cancer diagnostics, 2023-2032 (USD Million)
• TABLE 292. Latin America oncology market size, by cancer treatment, 2018-2022 (USD Million)
• TABLE 293. Latin America oncology market size, by cancer treatment, 2023-2032 (USD Million)
• TABLE 294. Latin America oncology market size, by cancer type, 2018-2022 (USD Million)
• TABLE 295. Latin America oncology market size, by cancer type, 2023-2032 (USD Million)
• TABLE 296. Latin America oncology market size, by end-use, 2018-2022 (USD Million)
• TABLE 297. Latin America oncology market size, by end-use, 2023-2032 (USD Million)
• TABLE 298. Brazil oncology market size, by cancer diagnostics & treatment, 2018-2022 (USD Million)
• TABLE 299. Brazil oncology market size, by cancer diagnostics & treatment, 2023-2032 (USD Million)
• TABLE 300. Brazil oncology market size, by cancer diagnostics, 2018-2022 (USD Million)
• TABLE 301. Brazil oncology market size, by cancer diagnostics, 2023-2032 (USD Million)
• TABLE 302. Brazil oncology market size, by cancer treatment, 2018-2022 (USD Million)
• TABLE 303. Brazil oncology market size, by cancer treatment, 2023-2032 (USD Million)
• TABLE 304. Brazil oncology market size, by cancer type, 2018-2022 (USD Million)
• TABLE 305. Brazil oncology market size, by cancer type, 2023-2032 (USD Million)
• TABLE 306. Brazil oncology market size, by end-use, 2018-2022 (USD Million)
• TABLE 307. Brazil market size, by end-use, 2023-2032 (USD Million)
• TABLE 308. Mexico oncology market size, by cancer diagnostics & treatment, 2018-2022 (USD Million)
• TABLE 309. Mexico oncology market size, by cancer diagnostics & treatment, 2023-2032 (USD Million)
• TABLE 310. Mexico oncology market size, by cancer diagnostics, 2018-2022 (USD Million)
• TABLE 311. Mexico oncology market size, by cancer diagnostics, 2023-2032 (USD Million)
• TABLE 312. Mexico oncology market size, by cancer treatment, 2018-2022 (USD Million)
• TABLE 313. Mexico oncology market size, by cancer treatment, 2023-2032 (USD Million)
• TABLE 314. Mexico oncology market size, by cancer type, 2018-2022 (USD Million)
• TABLE 315. Mexico oncology market size, by cancer type, 2023-2032 (USD Million)
• TABLE 316. Mexico oncology market size, by end-use, 2018-2022 (USD Million)
• TABLE 317. Mexico oncology market size, by end-use, 2023-2032 (USD Million)
• TABLE 318. Argentina oncology market size, by cancer diagnostics & treatment, 2018-2022 (USD Million)
• TABLE 319. Argentina oncology market size, by cancer diagnostics & treatment, 2023-2032 (USD Million)
• TABLE 320. Argentina oncology market size, by cancer diagnostics, 2018-2022 (USD Million)
• TABLE 321. Argentina oncology market size, by cancer diagnostics, 2023-2032 (USD Million)
• TABLE 322. Argentina oncology market size, by cancer treatment, 2018-2022 (USD Million)
• TABLE 323. Argentina oncology market size, by cancer treatment, 2023-2032 (USD Million)
• TABLE 324. Argentina oncology market size, by cancer type, 2018-2022 (USD Million)
• TABLE 325. Argentina oncology market size, by cancer type, 2023-2032 (USD Million)
• TABLE 326. Argentina oncology market size, by end-use, 2018-2022 (USD Million)
• TABLE 327. Argentina oncology market size, by end-use, 2023-2032 (USD Million)
• TABLE 328. Columbia oncology market size, by cancer diagnostics & treatment, 2018-2022 (USD Million)
• TABLE 329. Columbia oncology market size, by cancer diagnostics & treatment, 2023-2032 (USD Million)
• TABLE 330. Columbia oncology market size, by cancer diagnostics, 2018-2022 (USD Million)
• TABLE 331. Columbia oncology market size, by cancer diagnostics, 2023-2032 (USD Million)
• TABLE 332. Columbia oncology market size, by cancer treatment, 2018-2022 (USD Million)
• TABLE 333. Columbia oncology market size, by cancer treatment, 2023-2032 (USD Million)
• TABLE 334. Columbia oncology market size, by cancer type, 2018-2022 (USD Million)
• TABLE 335. Columbia oncology market size, by cancer type, 2023-2032 (USD Million)
• TABLE 336. Columbia oncology market size, by end-use, 2018-2022 (USD Million)
• TABLE 337. Columbia oncology market size, by end-use, 2023-2032 (USD Million)
• TABLE 338. MEA oncology market size, by country, 2018-2022 (USD Million)
• TABLE 339. MEA oncology market size, by country, 2023-2032 (USD Million)
• TABLE 340. MEA oncology market size, by cancer diagnostics & treatment, 2018-2022 (USD Million)
• TABLE 341. MEA oncology market size, by cancer diagnostics & treatment, 2023-2032 (USD Million)
• TABLE 342. MEA oncology market size, by cancer diagnostics, 2018-2022 (USD Million)
• TABLE 343. MEA oncology market size, by cancer diagnostics, 2023-2032 (USD Million)
• TABLE 344. MEA oncology market size, by cancer treatment, 2018-2022 (USD Million)
• TABLE 345. MEA oncology market size, by cancer treatment, 2023-2032 (USD Million)
• TABLE 346. MEA oncology market size, by cancer type, 2018-2022 (USD Million)
• TABLE 347. MEA oncology market size, by cancer type, 2023-2032 (USD Million)
• TABLE 348. MEA oncology market size, by end-use, 2018-2022 (USD Million)
• TABLE 349. MEA oncology market size, by end-use, 2023-2032 (USD Million)
• TABLE 350. South Africa oncology market size, by cancer diagnostics & treatment, 2018-2022 (USD Million)
• TABLE 351. South Africa oncology market size, by cancer diagnostics & treatment, 2023-2032 (USD Million)
• TABLE 352. South Africa oncology market size, by cancer diagnostics, 2018-2022 (USD Million)
• TABLE 353. South Africa oncology market size, by cancer diagnostics, 2023-2032 (USD Million)
• TABLE 354. South Africa oncology market size, by cancer treatment, 2018-2022 (USD Million)
• TABLE 355. South Africa oncology market size, by cancer treatment, 2023-2032 (USD Million)
• TABLE 356. South Africa oncology market size, by cancer type, 2018-2022 (USD Million)
• TABLE 357. South Africa oncology market size, by cancer type, 2023-2032 (USD Million)
• TABLE 358. South Africa oncology market size, by end-use, 2018-2022 (USD Million)
• TABLE 359. South Africa market size, by end-use, 2023-2032 (USD Million)
• TABLE 360. Saudi Arabia oncology market size, by cancer diagnostics & treatment, 2018-2022 (USD Million)
• TABLE 361. Saudi Arabia oncology market size, by cancer diagnostics & treatment, 2023-2032 (USD Million)
• TABLE 362. Saudi Arabia oncology market size, by cancer diagnostics, 2018-2022 (USD Million)
• TABLE 363. Saudi Arabia oncology market size, by cancer diagnostics, 2023-2032 (USD Million)
• TABLE 364. Saudi Arabia oncology market size, by cancer treatment, 2018-2022 (USD Million)
• TABLE 365. Saudi Arabia oncology market size, by cancer treatment, 2023-2032 (USD Million)
• TABLE 366. Saudi Arabia oncology market size, by cancer type, 2018-2022 (USD Million)
• TABLE 367. Saudi Arabia oncology market size, by cancer type, 2023-2032 (USD Million)
• TABLE 368. Saudi Arabia oncology market size, by end-use, 2018-2022 (USD Million)
• TABLE 369. Saudi Arabia oncology market size, by end-use, 2023-2032 (USD Million)
• TABLE 370. UAE oncology market size, by cancer diagnostics & treatment, 2018-2022 (USD Million)
• TABLE 371. UAE oncology market size, by cancer diagnostics & treatment, 2023-2032 (USD Million)
• TABLE 372. UAE oncology market size, by cancer diagnostics, 2018-2022 (USD Million)
• TABLE 373. UAE oncology market size, by cancer diagnostics, 2023-2032 (USD Million)
• TABLE 374. UAE oncology market size, by cancer treatment, 2018-2022 (USD Million)
• TABLE 375. UAE oncology market size, by cancer treatment, 2023-2032 (USD Million)
• TABLE 376. UAE oncology market size, by cancer type, 2018-2022 (USD Million)
• TABLE 377. UAE oncology market size, by cancer type, 2023-2032 (USD Million)
• TABLE 378. UAE oncology market size, by end-use, 2018-2022 (USD Million)
• TABLE 379. UAE oncology market size, by end-use, 2023-2032 (USD Million)
• TABLE 380. Israel oncology market size, by cancer diagnostics & treatment, 2018-2022 (USD Million)
• TABLE 381. Israel oncology market size, by cancer diagnostics & treatment, 2023-2032 (USD Million)
• TABLE 382. Israel oncology market size, by cancer diagnostics, 2018-2022 (USD Million)
• TABLE 383. Israel oncology market size, by cancer diagnostics, 2023-2032 (USD Million)
• TABLE 384. Israel oncology market size, by cancer treatment, 2018-2022 (USD Million)
• TABLE 385. Israel oncology market size, by cancer treatment, 2023-2032 (USD Million)
• TABLE 386. Israel oncology market size, by cancer type, 2018-2022 (USD Million)
• TABLE 387. Israel oncology market size, by cancer type, 2023-2032 (USD Million)
• TABLE 388. Israel oncology market size, by end-use, 2018-2022 (USD Million)
• TABLE 389. Israel oncology market size, by end-use, 2023-2032 (USD Million)

Charts & Figures

• Fig.1 GMI report coverage: critical research elements
• Fig.2 Industry segmentation
• Fig.3 Top-down approach
• Fig.4 Market forecasting methodology
• Fig.5 Profile break-up of primary respondents
• Fig.6 Oncology industry 360 degree synopsis, 2018 - 2032
• Fig.7 Global oncology market size, 2018 - 2032, (USD Million)
• Fig.8 Growth potential analysis, by cancer treatment & diagnostics
• Fig.9 Growth potential analysis, by cancer type
• Fig.10 Growth potential analysis, by end-use
• Fig.11 Porter's analysis
• Fig.12 PESTEL analysis
• Fig.13 Company matrix analysis
• Fig.14 Competitive analysis of major market players
• Fig.15 Oncology drugs company market share analysis, 2021
• Fig.16 Strategy dashboard

Oncology Market is expected to garner commendable gains over 2023 to 2032, fueled by the growing cancer prevalence worldwide. As per WHO statistics, cancer is one of the leading causes of fatalities worldwide, resulting in nearly 10 million deaths in 2020. This calls for broad treatment options to treat the disease. Various therapies such as chemotherapy, surgery, and radiation therapy are employed in cancer therapy subject to the pivotal benefits in terms of providing palliative as well as curative effect in cancer treatment.

Technological innovations by researchers, government officials, and market players in developed economies would further influence the industry growth through 2032. For instance, the Government Office for Technology Transfer (GOTT), UK, funded the National Physical Laboratory's novel development of ultrasound technology to enhance breast cancer diagnosis.

The oncology industry is segmented into cancer diagnostics and treatment, cancer, end-use, and region.

Based on cancer diagnostics and treatment, the cancer diagnostics segment is slated to churn profitable returns over the due course of time. Fundamental factors driving the segmental growth include growing incidences of cancer and technological advancements in the space. In addition, detecting cancer with only physical exams or biomarker tests is noted to be a monotonous task while imaging test is essential for conformation. These trends thus prompt the demand for advanced imaging modalities, stimulating the market growth.

Considering the cancer, oncology market share from breast cancer segment would accrue massive gains over the next ten years, owing to the alarming breast cancer incidences due to rising obesity, hormonal imbalance cases, and age-related risks. As per Cancer.net statistics, it has been projected that breast cancer could lead to more than 43,500 deaths in the United States in 2023. Besides, various government efforts such as BreastScreen Aotearoa in New Zealand and other countries, providing free tests to women would further boost the market size.

Oncology treatment is being largely accommodated in specialty clinics over the recent years. These healthcare settings stand as advanced cancer care establishments that cater to specific types of cancer treatments. Increased availability of advanced technology for detection and screening and specialist oncologists across these settings would further encourage the business growth.

Not to mention, growing availability of advanced technology for screening and diagnosis would offer attractive opportunities to patients for cancer treatment.

Regionally, Asia Pacific is likely to emerge as a regional hotspot for oncology industry. As per reports, the APAC oncology market is predicted to grow at more than 11.5% CAGR between 2023 to 2032. The regional growth can be credited to the burgeoning cases of cancer in countries such as India, Japan, and China. For the record, a cancer registry data reveals that there would be approximately 800,000 new cancer cases in India every year.

Furthermore, growing cognizance among the regional population about the newly developed cancer medications by key pharmaceutical companies in the Asia Pacific would foster the regional market growth in the years ahead.

Table of Contents

Chapter 1 Methodology & Scope

• 1.1 Methodology
• 1.2 Market scope and definitions
• 1.3 Base estimates and working
• 1.4 Forecast parameters
• 1.5 COVID-19 impact analysis at global level
• 1.6 Data validation
• 1.7 Data sources
  • 1.7.1 Primary
  • 1.7.2 Secondary
    • 1.7.2.1 Paid sources
    • 1.7.2.2 Unpaid sources

Chapter 2 Executive Summary

• 2.1 Oncology industry 360 degree synopsis, 2018 - 2032
  • 2.1.1 Business trends
  • 2.1.2 Cancer diagnostic & treatment trends
  • 2.1.3 Cancer type trends
  • 2.1.4 End-use trends
  • 2.1.5 Regional trends

Chapter 3 Oncology Industry Insights

• 3.1 Industry segmentation
• 3.2 Industry landscape, 2018 - 2032
• 3.3 Industry impact forces
  • 3.3.1 Growth drivers
    • 3.3.1.1 Rising incidence of cancer globally
    • 3.3.1.2 Several initiatives undertaken by government and other organizations to spread disease awareness
    • 3.3.1.3 Growing number of diagnostic laboratories in developing countries
    • 3.3.1.4 Technological advancements in developed countries
  • 3.3.2 Industry pitfalls & challenges
    • 3.3.2.1 High capital investment coupled with high cost associated with diagnostic imaging system
    • 3.3.2.2 High risk of side effects associated with cancer treatment and risks associated with CT scanners
    • 3.3.2.3 Dearth of well-skilled and trained oncologists and radiologists
• 3.4 Growth potential analysis
  • 3.4.1 By cancer diagnostics & treatment
  • 3.4.2 By cancer type
  • 3.4.3 By end-use
• 3.5 COVID- 19 impact analysis
• 3.6 Oncology clinical trial volume analysis, 2021
  • 3.6.1 Oncology clincial trial volume, by region, 2017 - 2021
  • 3.6.2 Oncology clinical trial volume, by cancer type, 2017 - 2021
  • 3.6.3 Oncology clinical trial volume, by phase of development, 2017 - 2021
• 3.7 Pipeline analysis
• 3.8 Porter's analysis
• 3.9 PESTEL analysis

Chapter 4 Competitive Landscape, 2021

• 4.1 Introduction
• 4.2 Company matrix analysis
• 4.3 Top oncology drugs, by company, 2021
• 4.4 Competitive analysis of major market players
  • 4.4.1 F. Hoffmann-La Roche
  • 4.4.2 Janssen Diagnostics, LCC
  • 4.4.3 Pfizer, Inc
  • 4.4.4 GE Healthcare
• 4.5 Oncology drugs company market share analysis, 2021
• 4.6 Strategic dashboard

Chapter 5 Oncology Market, By Cancer Diagnostics & Treatment

• 5.1 Key cancer diagnostics & treatment trends
• 5.2 Cancer diagnostics
  • 5.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
  • 5.2.2 Tumor biomarkers tests
    • 5.2.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
  • 5.2.3 Imaging
    • 5.2.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
  • 5.2.4 Biopsy
    • 5.2.4.1 Market estimates and forecast, 2018 - 2032 (USD Million)
  • 5.2.5 Liquid biopsy
    • 5.2.5.1 Market estimates and forecast, 2018 - 2032 (USD Million)
  • 5.2.6 Immunohistochemistry
    • 5.2.6.1 Market estimates and forecast, 2018 - 2032 (USD Million)
  • 5.2.7 In situ hybridization
    • 5.2.7.1 Market estimates and forecast, 2018 - 2032 (USD Million)
• 5.3 Cancer treatment
  • 5.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
  • 5.3.2 Immunohistochemistry
    • 5.3.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
  • 5.3.3 Targeted therapy
    • 5.3.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
  • 5.3.4 Immunotherapy
    • 5.3.4.1 Market estimates and forecast, 2018 - 2032 (USD Million)
  • 5.3.5 Hormonal therapy
    • 5.3.5.1 Market estimates and forecast, 2018 - 2032 (USD Million)
  • 5.3.6 Others
    • 5.3.6.1 Market estimates and forecast, 2018 - 2032 (USD Million)

Chapter 6 Oncology Market, By Cancer Type

• 6.1 Key cancer type trends
• 6.2 Lung cancer
  • 6.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
• 6.3 Prostate cancer
  • 6.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
• 6.4 Colon & rectal cancer
  • 6.4.1 Market estimates and forecast, 2018 - 2032 (USD Million)
• 6.5 Gastric cancer
  • 6.5.1 Market estimates and forecast, 2018 - 2032 (USD Million)
• 6.6 Esophageal cancer
  • 6.6.1 Market estimates and forecast, 2018 - 2032 (USD Million)
• 6.7 Liver cancer
  • 6.7.1 Market estimates and forecast, 2018 - 2032 (USD Million)
• 6.8 Breast cancer
  • 6.8.1 Market estimates and forecast, 2018 - 2032 (USD Million)
• 6.9 Others
  • 6.9.1 Market estimates and forecast, 2018 - 2032 (USD Million)

Chapter 7 Oncology Market, By End-use

• 7.1 Key end-use trends
• 7.2 Hospitals
  • 7.2.1 Market estimates and forecast, 2018 - 2032 (USD Million)
• 7.3 Diagnostic laboratories
  • 7.3.1 Market estimates and forecast, 2018 - 2032 (USD Million)
• 7.4 Diagnostic imaging centers
  • 7.4.1 Market estimates and forecast, 2018 - 2032 (USD Million)
• 7.5 Academia
  • 7.5.1 Market estimates and forecast, 2018 - 2032 (USD Million)
• 7.6 Specialty clinics
  • 7.6.1 Market estimates and forecast, 2018 - 2032 (USD Million)
• 7.7 Others
  • 7.7.1 Market estimates and forecast, 2018 - 2032 (USD Million)

Chapter 8 Oncology Market, By Region

• 8.1 Key regional trends
• 8.2 North America
  • 8.2.1 U.S.
  • 8.2.2 Canada
• 8.3 Europe
  • 8.3.1 Germany
  • 8.3.2 UK
  • 8.3.3 France
  • 8.3.4 Spain
  • 8.3.5 Italy
  • 8.3.6 Poland
  • 8.3.7 Switzerland
  • 8.3.8 Netherlands
• 8.4 Asia Pacific
  • 8.4.1 China
  • 8.4.2 India
  • 8.4.3 Japan
  • 8.4.4 Australia
  • 8.4.5 South Korea
  • 8.4.6 Indonesia
  • 8.4.7 Thailand
  • 8.4.8 Vietnam
• 8.5 Latin America
  • 8.5.1 Brazil
  • 8.5.2 Mexico
  • 8.5.3 Argentina
  • 8.5.4 Columbia
• 8.6 MEA
  • 8.6.1 South Africa
  • 8.6.2 Saudi Arabia
  • 8.6.3 UAE
  • 8.6.4 Israel

Chapter 9 Company Profiles

• 9.1 Abbott
• 9.2 Bayer AG
• 9.3 Biocartis
• 9.4 BioMerieux SA
• 9.5 Bio-Rad Laboratories
• 9.6 GE Healthcare
• 9.7 Astellas Pharma, Inc.
• 9.8 AstraZeneca
• 9.9 Janssen Diagnostic LLC (Johnson & Johnson)
• 9.10 F. Hoffmann-La Roche Ltd
• 9.11 Sysmex Corporation
• 9.12 Thermo Fischer Scientific
• 9.13 Siemens Healthineers
• 9.14 Kite Pharma (Gilead Sciences Inc)
• 9.15 Amgen
• 9.16 AstraZeneca
• 9.17 Merck & Co.
• 9.18 Abbive Inc.
• 9.19 Pfizer